非手术治疗原发性肝癌的现状与进展  

Current status and progress on non-surgical treatment of patients with primary liver cancer

作　　者：车斯尧[1] 何龙光[1] 陈钦寿[1] 黄思敏[1] 

机构地区：[1]高州市人民医院肝胆外科,广东省525200

出　　处：《中华肝胆外科杂志》2016年第6期428-432,共5页Chinese Journal of Hepatobiliary Surgery

摘　　要：原发性肝癌（ PLC）是世界上常见的恶性肿瘤，严重影响着人们的健康。虽然目前 PLC 的治疗方法较多，但是总体治疗效果仍不理想。近年来，随着消融、介入、化疗、放射及分子靶向治疗技术的发展，非手术治疗方式在肝癌综合治疗中起着越来越重要的作用。而个体化的多学科综合治疗模式也将是今后肝癌治疗的重要发展方向。本文就肝癌的非手术治疗的现状及其进展作简要综述。Primary liver cancer （ PLC） , the most com-mon malignant carcinoma in the world , greatly impairs the hu-man health .Various treatments for PLC have been practiced but the therapeutic effects are still unsatisfied .Nowadays, interven-tional therapy , chemotherapy , radiotherapy , molecular targeted therapy and radiofrequency ablation are playing a key role in hepatocellular carcinoma treatment .In near future , more ad-vancements on comprehensive therapy for PLC are being expec-ted.This review aimed to describe the recent scenario and cur-rent advancement on non-surgical treatment for hepatocellular carcinoma .

关 键 词：肝癌 非手术治疗 

分 类 号：R735.7[医药卫生—肿瘤]